Announcing the September 29, 2016 Meeting of San Diego Women In Finance
Biotech Panel Discussion 2016
Join us for a stimulating evening of conversation with our accomplished panelist.
Panelists: Anila Dhokia, Laurie Stelzer, Cris Calsada and Moderator: Ellen Hoffman MBA.
Address: 5200 Illumina Way, San Diego, CA 92122
Date: Thursday, September 29, 2016
Time: Networking – 5:00 p.m., Presentation – 6:00 p.m.
Join us for this stimulating evening of conversation with our accomplished panelists who will be discussing the Biotech Industry in 2016.
Anila Dhokia joined Illumina Inc. in April 2015, as Senior Director, Head of Internal Audit. She is focused on delivering the company’s Internal Audit and Sarbanes-Oxley (SOX) mandates, developing her team while building out the audit function, and partnering with the business to ensure controls continue to be at the core of strategic decision-making. She is an active member of the Women’s Leadership Network at Illumina, and thrives on building leaders at all levels, through dedicated mentoring of individuals, both internally and externally. Prior to arriving at Illumina, Anila spent two years in Redmond, WA as the Controller for Microsoft’s Information Technology organization. Prior to Microsoft, Anila held a variety of progressively senior Finance positions within Accounting and Control, FP&A, Tax and Internal Audit, over a 17 year career at Nortel Networks. Anila holds a Bachelor of Science in Chemistry from McMaster University, an MBA from Laurentian University and is a Certified Professional Accountant (CPA, CA) from Canada.
Laurie Stelzer joined Halozyme in June 2015 as Senior Vice President, Chief Financial Officer. At Halozyme, she is responsible for the Finance, IT, and Hylenex Commercial organizations. Prior to joining Halozyme, Laurie served as the Senior Vice President of Finance supporting R&D, Technical Operations and M&A at Shire, Inc. Other roles at Shire included the Head of Investor Relations and the Division CFO for the Regenerative Medicine Division, located in San Diego. Prior to Shire, Laurie held positions of increasing responsibility for 15 years at Amgen, Inc. including Interim Treasurer, Head of Emerging Markets and International Business Development, Executive Director of Global Commercial Finance and Head of Global Accounting. Early in her career, she held various finance and accounting positions in the real estate and banking industries. Laurie received her MBA from the Anderson School at the University of California, Los Angeles, a Bachelor of Science in Accounting from Arizona State University, and is a CPA (inactive) in Arizona.
Cris Calsada has over 20 years of accounting, finance and operations experience. Ms. Calsada was Chief Operating Officer and Vice President of Finance of Ambrx, Inc. until its acquisition in June 2015. Ms. Calsada served as Executive Director of Finance at Sony Online Entertainment from 1999 to 2004. Prior to that, she worked for six years in public accounting and private industry. Ms. Calsada is a certified public accountant and holds an M.B.A. from the University of Southern California Marshall School of Business and a B.S. in Business Administration with an emphasis in Accounting from San Diego State University.
Ellen R Hoffman, MBA San Diego Women in Finance Co-Founder and Corporate Treasurer Executive will moderate the panel.
About Our Corporate Sponsors:
At Illumina, our goal is to apply innovative sequencing and array technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative sequencing and array-based solutions for genomic analysis serve as tools for disease research, drug discovery, and the development of molecular tests in clinical labs.
Executive Search for Finance & Accounting
A business line of Roth Staffing Companies, L.P.
As a division of Roth Staffing, Ledgent remains the only staffing company ever to be ranked #1 on the Inc. 500, recognizing us as the fastest growing privately-held company in the United States over a 5 year period. We have won multiple awards based on our alignment with the Malcolm Baldrige Criteria for Performance Excellence. Today, we are one of the nation’s largest privately-held staffing companies with branches throughout the United States